These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 36737790)
1. Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities. Tauziède-Espariat A; Hasty L; Métais A; Varlet P Acta Neuropathol Commun; 2023 Feb; 11(1):22. PubMed ID: 36737790 [TBL] [Abstract][Full Text] [Related]
2. Expanding the spectrum of "mesenchymal" tumors of the central nervous system. Pizzimenti C; Gianno F; Gessi M Pathologica; 2022 Dec; 114(6):455-464. PubMed ID: 36534424 [TBL] [Abstract][Full Text] [Related]
3. [Mesenchymal and Non-meningothelial Tumors Involving the Central Nervous System]. Oya S; Murakami C No Shinkei Geka; 2023 Sep; 51(5):837-844. PubMed ID: 37743335 [TBL] [Abstract][Full Text] [Related]
5. Central nervous system tumors of uncertain differentiation. A Jacobo J World Neurosurg X; 2024 Apr; 22():100349. PubMed ID: 38455248 [TBL] [Abstract][Full Text] [Related]
6. Embryonal tumors in the WHO CNS5 classification: A Review. Gianno F; Miele E; Antonelli M; Giangaspero F Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137 [TBL] [Abstract][Full Text] [Related]
8. Primary central nervous system sarcoma with DICER1 mutation-treatment results of a novel molecular entity in pediatric Peruvian patients. Diaz Coronado RY; Mynarek M; Koelsche C; Mora Alferez P; Casavilca Zambrano S; Wachtel Aptowitzer A; Sahm F; von Deimling A; Schüller U; Spohn M; Sturm D; Pfister SM; Morales La Madrid A; Sernaque Quintana R; Sarria Bardales G; Negreiros Chinchihuara T; Ojeda Medina L; Garcia-Corrochano Medina P; Campos Sanchez DA; Ponce Farfan J; Rutkowski S; Garcia Leon JL Cancer; 2022 Feb; 128(4):697-707. PubMed ID: 34674226 [TBL] [Abstract][Full Text] [Related]
9. Mesenchymal, non-meningothelial tumors of the central nervous system. Jellinger K; Paulus W Brain Pathol; 1991 Jan; 1(2):79-87. PubMed ID: 1669699 [TBL] [Abstract][Full Text] [Related]
10. A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genes. Tauziède-Espariat A; Pierron G; Guillemot D; Sievers P; Cazals-Hatem D; Faillot T; Roux A; Benzakoun J; Bockel S; Weinbreck N; Hasty L; Lechapt E; Chrétien F; Varlet P Acta Neuropathol Commun; 2021 Oct; 9(1):174. PubMed ID: 34715942 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system. Gritsch S; Batchelor TT; Gonzalez Castro LN Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681 [TBL] [Abstract][Full Text] [Related]
12. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations. Koelsche C; Mynarek M; Schrimpf D; Bertero L; Serrano J; Sahm F; Reuss DE; Hou Y; Baumhoer D; Vokuhl C; Flucke U; Petersen I; Brück W; Rutkowski S; Zambrano SC; Garcia Leon JL; Diaz Coronado RY; Gessler M; Tirado OM; Mora J; Alonso J; Garcia Del Muro X; Esteller M; Sturm D; Ecker J; Milde T; Pfister SM; Korshunov A; Snuderl M; Mechtersheimer G; Schüller U; Jones DTW; von Deimling A Acta Neuropathol; 2018 Aug; 136(2):327-337. PubMed ID: 29881993 [TBL] [Abstract][Full Text] [Related]
13. DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor. Kamihara J; Paulson V; Breen MA; Laetsch TW; Rakheja D; Shulman DS; Schoettler ML; Clinton CM; Ward A; Reidy D; Pinches RS; Weiser DA; Mullen EA; Schienda J; Meyers PA; DuBois SG; Nowak JA; Foulkes WD; Schultz KAP; Janeway KA; Vargas SO; Church AJ Mod Pathol; 2020 Oct; 33(10):1910-1921. PubMed ID: 32291395 [TBL] [Abstract][Full Text] [Related]
14. Central nervous system sarcoma with ATXN1::DUX4 fusion expands the concept of CIC-rearranged sarcoma. Satomi K; Ohno M; Kubo T; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Ichikawa H; Yoshida A Genes Chromosomes Cancer; 2022 Nov; 61(11):683-688. PubMed ID: 35715887 [TBL] [Abstract][Full Text] [Related]
15. Some CNS sarcomas seen: A 22-year series. Kleinschmidt-DeMasters BK; Gilani A Clin Neuropathol; 2023; 42(2):54-65. PubMed ID: 36708209 [TBL] [Abstract][Full Text] [Related]
16. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931 [TBL] [Abstract][Full Text] [Related]
17. All pineal tumors expressing germ cell tumor markers are not necessarily germ cell tumors: histopathological and molecular study of a midline primary intracranial sarcoma DICER1-mutant. Wolf T; Coca AH; Weingertner N; Chenard MP; Meurgey A; Reita D; Pencreach E; Varlet P; Entz-Werlé N; Lhermitte B Virchows Arch; 2023 Feb; 482(2):431-435. PubMed ID: 36307659 [TBL] [Abstract][Full Text] [Related]
19. [The 2021 WHO classification of tumours of the central nervous system]. Figarella-Branger D; Appay R; Metais A; Tauziède-Espariat A; Colin C; Rousseau A; Varlet P Ann Pathol; 2022 Oct; 42(5):367-382. PubMed ID: 34865882 [TBL] [Abstract][Full Text] [Related]
20. An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts. Tauziède-Espariat A; Sievers P; Larousserie F; Benzakoun J; Guillemot D; Pierron G; Duchesne M; Uro-Coste E; Roux A; Vasiljevic A; Fenouil T; Meyronet D; Mokhtari K; Polivka M; Rousseau A; Bost-Bezeaud F; Akoury S; Pallud J; Benevello C; Hasty L; Gareton A; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Puget S; Sahm F; Varlet P; Brain Pathol; 2022 Jan; 32(1):e13010. PubMed ID: 34314078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]